- List
- By Topic
- On Map
- Search Details

endometriosis (348 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
101 | NCT01291576 | Active, not recruiting | Functional Outcomes of Surgical Management of Deep Endometriosis Infiltrating the Rectum |
|
|
Interventional | Not Applicable |
|
Other |
|
|
60 | Female | 18 Years to 45 Years (Adult) | NCT01291576 | 2009/069/HP | ENDORE | March 2011 | September 2013 | September 2023 | February 8, 2011 | June 14, 2017 |
|
|
102 | NCT00194233 | Completed | Serum and Peritoneal Fluid Bank for Endometriosis Markers |
|
Observational |
|
Other |
|
300 | Female | 18 Years to 50 Years (Adult) | NCT00194233 | 708870 RRU008 |
November 2003 | January 2007 | June 2008 | September 19, 2005 | August 16, 2016 |
|
|||||
103 | NCT03126747 | Recruiting | Drug Use Investigation (DUI) of YazFlex for Endometriosis-associated Pelvic Pain and/or Dysmenorrhea |
|
|
Observational |
|
Industry |
|
|
600 | Female | Child, Adult, Senior | NCT03126747 | 18703 | June 29, 2017 | June 30, 2020 | December 30, 2020 | April 24, 2017 | April 17, 2018 |
|
|||
104 | NCT01412138 | Unknown † | Somatic Stem Cells in Endometriosis |
|
|
Observational |
|
Industry |
|
|
30 | Female | 20 Years to 40 Years (Adult) | NCT01412138 | 1006-C-073-CS-F | March 2011 | April 2016 | April 2016 | August 9, 2011 | April 22, 2015 |
|
|||
105 | NCT02636400 | Active, not recruiting | Immediate Intra Uterine Isemination (IUI) Versus Expectant Management in Postoperative Endometriosis Patients |
|
|
Interventional | Not Applicable |
|
Other |
|
|
24 | Female | 18 Years to 37 Years (Adult) | NCT02636400 | S55983 | February 2014 | June 2017 | December 2018 | December 21, 2015 | October 26, 2017 |
|
||
106 | NCT03204331 | Recruiting | SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
600 | Female | 18 Years to 50 Years (Adult) | NCT03204331 | MVT-601-3102 | August 30, 2017 | December 2019 | June 2020 | July 2, 2017 | April 3, 2018 |
|
||
107 | NCT03204318 | Recruiting | SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
600 | Female | 18 Years to 50 Years (Adult) | NCT03204318 | MVT-601-3101 | June 27, 2017 | December 2019 | June 2020 | July 2, 2017 | February 26, 2018 |
|
||
108 | NCT01973816 | Recruiting | MEdical Versus SUrgical Treatments of Rectal Endometriosis |
|
|
Interventional | Phase 3 |
|
Other |
|
|
78 | Female | 35 Years to 50 Years (Adult) | NCT01973816 | 2013/001/HP | MESURE | November 2014 | March 2018 | November 2019 | November 1, 2013 | June 14, 2017 |
|
|
109 | NCT03305120 | Completed | Musculo-scrawny Manifestation Associated With the Endometriosis |
|
|
Observational |
|
Other |
|
|
41 | Female | 18 Years to 45 Years (Adult) | NCT03305120 | ENDOMETRI-OS | September 16, 2016 | October 16, 2016 | December 31, 2016 | October 9, 2017 | October 9, 2017 |
|
|||
110 | NCT01620528 | Completed | A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
872 | Female | 18 Years to 49 Years (Adult) | NCT01620528 | M12-665 | May 2012 | November 2014 | September 2015 | June 15, 2012 | March 21, 2017 |
|
||
111 | NCT02158845 | Completed | Levonorgestrel-releasing Intrauterine System in Patients With Endometriosis |
|
|
Interventional | Phase 4 |
|
Other |
|
|
44 | Female | 18 Years to 40 Years (Adult) | NCT02158845 | SIU-LNG 001 | SIU-LNG | February 2010 | September 2012 | September 2012 | June 9, 2014 | January 21, 2015 |
|
|
112 | NCT03017989 | Recruiting | ICG-Based Fluorescence Imaging for Intra-operative Detection of Endometriosis |
|
|
Interventional | Not Applicable |
|
Other |
|
|
15 | Female | 18 Years and older (Adult, Senior) | NCT03017989 | NL54458.068.15 | January 2017 | August 2018 | December 2018 | January 11, 2017 | March 22, 2018 |
|
||
113 | NCT01760954 | Completed | Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
506 | Female | 18 Years to 50 Years (Adult) | NCT01760954 | M12-667 | December 2012 | May 2015 | March 2016 | January 4, 2013 | January 5, 2018 |
|
||
114 | NCT01682642 | Completed Has Results |
The Influence of Adjuvant Medical Treatment of Peritoneal Endometriosis on the Outcome of IVF. A Prospective Randomized Analysis. |
|
|
Interventional | Phase 4 |
|
Other |
|
|
120 | Female | 18 Years to 38 Years (Adult) | NCT01682642 | 2012-000784-25 | March 2012 | October 2014 | October 2014 | September 11, 2012 | March 20, 2015 | March 20, 2015 |
|
|
115 | NCT02165917 | Unknown † | Study to Compare Peritoneal Ablation by Excision Only and Excision With the Use of an Adhesion Barrier |
|
|
Interventional | Phase 4 |
|
Other |
|
|
60 | Female | 18 Years to 45 Years (Adult) | NCT02165917 | PHDW-003 | May 2015 | May 2017 | May 2017 | June 18, 2014 | November 3, 2015 |
|
||
116 | NCT03232281 | Recruiting | Study to Compare the Oestradiol Suppression, Clinical Efficacy and Safety of Two Formulations of Triptorelin (Triptorelin Pamoate PR 3-month and Triptorelin Acetate PR 1-month) in Chinese Subjects With Endometriosis |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
300 | Female | 18 Years to 45 Years (Adult) | NCT03232281 | D-CN-52014-220 | July 28, 2017 | February 28, 2019 | February 28, 2019 | July 27, 2017 | February 27, 2018 |
|
||
117 | NCT02921763 | Active, not recruiting | A Survey on Efficacy and Safety in Patients With Endometriosis |
|
|
Observational |
|
Industry |
|
|
60 | Female | 20 Years to 49 Years (Adult) | NCT02921763 | DUPKST16002 | August 2016 | October 2017 | October 2017 | October 3, 2016 | May 25, 2017 |
|
|||
118 | NCT01712763 | Completed | Degarelix in the Treatment of Endometriosis Recurrence |
|
|
Interventional | Phase 3 |
|
Other |
|
|
100 | Female | 20 Years to 45 Years (Adult) | NCT01712763 | C06/2012 | November 2012 | March 2016 | March 2016 | October 24, 2012 | April 27, 2016 |
|
||
119 | NCT02511626 | Active, not recruiting | Quality of Life in Endometriosis - a Case Control Study |
|
Observational |
|
Other |
|
|
1267 | Female | 18 Years and older (Adult, Senior) | NCT02511626 | Endo_QOL | January 2010 | December 2016 | December 2018 | July 30, 2015 | November 13, 2017 |
|
||||
120 | NCT00117481 | Completed | Evaluation of DR-2001 for the Management of Endometriosis-Related Pelvic Pain |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
90 | Female | 18 Years to 45 Years (Adult) | NCT00117481 | DR-DZL-201 | June 2005 | December 2007 | December 2007 | July 7, 2005 | May 9, 2014 |
|
||
121 | NCT03373422 | Recruiting | A Study to Test Whether Study Drug BAY1128688 Brings Pain Relief to Women With Endometriosis and if so to Get a First Idea Which Dose(s) Work Best |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
120 | Female | 18 Years and older (Adult, Senior) | NCT03373422 | 17472 2017-000244-18 |
AKRENDO1 | November 30, 2017 | March 29, 2019 | May 10, 2019 | December 14, 2017 | April 9, 2018 |
|
|
122 | NCT03161704 | Recruiting | Validation and Refinement of Noninvasive Diagnostic Biomarkers for Endometriosis, The ENDOmarker Protocol |
|
Observational |
|
Other / NIH |
|
|
500 | Female | 18 Years to 44 Years (Adult) | NCT03161704 | ENDOmarker | July 8, 2016 | January 2021 | January 2021 | May 22, 2017 | April 17, 2018 |
|
||||
123 | NCT01334762 | Completed | Efficacy of Letrozole and CC Alone in an IUI Program in Cases With Surgically Treated Minimal to Mild Endometriosis |
|
|
Interventional | Not Applicable |
|
Other |
|
|
136 | Female | 20 Years to 36 Years (Adult) | NCT01334762 | MU-157x FMH-92-B |
May 2007 | June 2010 | June 2010 | April 13, 2011 | April 13, 2011 |
|
||
124 | NCT00370123 | Withdrawn | The Immune Base of Endometriosis |
|
Observational |
|
Other |
|
50 | Female | 18 Years to 45 Years (Adult) | NCT00370123 | SHEBA-06-4251-RM-CTIL | September 2006 | August 30, 2006 | June 28, 2011 | ||||||||
125 | NCT01767090 | Completed | A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
912 | Female | 18 Years to 45 Years (Adult) | NCT01767090 | 1707-CL-0011 2012-002791-14 |
December 2012 | May 2015 | July 2015 | January 14, 2013 | August 13, 2015 |
|
||
126 | NCT01595724 | Completed | Daily Practice Treatment and Influence of Visanne on the Patient Assessment of Quality of Life |
|
|
Observational |
|
Industry |
|
|
3006 | Female | 18 Years and older (Adult, Senior) | NCT01595724 | 16108 VS1101 |
DIVA | May 2012 | July 2014 | May 2015 | May 10, 2012 | July 10, 2015 |
|
||
127 | NCT01321840 | Completed | Cortical Plasticity in a Complex Intervention for Endometriosis |
|
|
Interventional | Not Applicable |
|
Other |
|
|
60 | Female | 18 Years and older (Adult, Senior) | NCT01321840 | Jena-Endo-01 | March 2010 | December 2012 | December 2012 | March 24, 2011 | January 6, 2017 |
|
||
128 | NCT02542410 | Recruiting | Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot Study |
|
|
Interventional | Phase 2 |
|
Other |
|
|
14 | Female | 15 Years to 40 Years (Child, Adult) | NCT02542410 | P00018628 | May 2016 | January 2018 | March 2018 | September 7, 2015 | August 16, 2017 |
|
||
129 | NCT00115661 | Terminated | Use of Rosiglitazone in the Treatment of Endometriosis |
|
|
Interventional | Phase 2 |
|
NIH / Other |
|
|
25 | Female | 18 Years to 45 Years (Adult) | NCT00115661 | 2004-1013 1K23HD043952-01A2 |
July 2005 | May 2006 | May 2006 | June 24, 2005 | October 17, 2012 |
|
||
130 | NCT02427386 | Completed | Homeopathic Treatment of Chronic Pelvic Pain in Women With Endometriosis |
|
|
Interventional | Phase 4 |
|
Other |
|
|
50 | Female | 18 Years to 45 Years (Adult) | NCT02427386 | FMUSP | May 2014 | February 2016 | December 2016 | April 28, 2015 | February 24, 2017 | |||
131 | NCT02437175 | Active, not recruiting | Efficacy of Trace Elements in the Treatment of Endometriosis: a Pilot Study |
|
|
Interventional | Phase 3 |
|
Industry / Other |
|
|
99 | Female | 18 Years to 45 Years (Adult) | NCT02437175 | Pronutri-IIIa-001 | May 2015 | December 2018 | December 2018 | May 7, 2015 | April 4, 2018 |
|
||
132 | NCT01921634 | Recruiting | Endometriosis and the Appendix - Incidence and Pathologic Analysis |
|
|
Interventional | Not Applicable |
|
Other |
|
|
100 | Female | 18 Years to 51 Years (Adult) | NCT01921634 | 042383EP | August 2013 | January 2018 | January 2018 | August 13, 2013 | December 19, 2017 |
|
||
133 | NCT00437658 | Completed | Safety and Efficacy Study of NBI-56418 in Endometriosis |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
252 | Female | 18 Years to 49 Years (Adult) | NCT00437658 | NBI-56418-0603 | November 2006 | November 2008 | November 2008 | February 21, 2007 | January 8, 2013 |
|
||
134 | NCT00556075 | Terminated Has Results |
Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
67 | Female | 18 Years to 48 Years (Adult) | NCT00556075 | ZPE-201 | November 2007 | May 2009 | July 2009 | November 9, 2007 | August 25, 2014 | August 25, 2014 |
|
|
135 | NCT01402791 | Completed | Endometriosis: Sexual Dysfunction and Adaptation Strategies Among Couples |
|
|
Observational |
|
Other |
|
|
60 | All | 18 Years and older (Adult, Senior) | NCT01402791 | LOCAL/2011/SD-05 2011-A00564-37 |
DYSEXTRIOSE | January 2011 | December 2011 | December 2011 | July 26, 2011 | March 26, 2015 |
|
||
136 | NCT03352076 | Recruiting | Study to Determine Intraperitoneal,Tissue, Serum Concentrations of VML-0501 Following Five Days of Daily Vaginal Single Dose of VML-0501 (100 mg Danazol), in Comparison to Oral Danazol Capsules Daily 600 mg), in Women With Signs and Symptoms of Endometriosis Undergoing Laparoscopy |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
24 | Female | 18 Years to 42 Years (Adult) | NCT03352076 | VML-0501-001 | December 28, 2017 | May 2018 | July 2018 | November 24, 2017 | January 18, 2018 |
|
||
137 | NCT02669238 | Not yet recruiting | Evaluation of a Subcutaneous Progestogen Implants in the Medical Management of Painful Endometriosis |
|
|
Interventional | Phase 2 Phase 3 |
|
Other |
|
|
160 | Female | 18 Years to 45 Years (Adult) | NCT02669238 | 2015/CHU/03 | END-IMPACT | June 2017 | January 2020 | February 2020 | February 1, 2016 | January 18, 2017 | ||
138 | NCT00121953 | Withdrawn | Effect of Rosiglitazone on Peritoneal Cytokines in Women With Endometriosis |
|
|
Interventional | Phase 2 Phase 3 |
|
NIH |
|
|
0 | Female | 18 Years to 45 Years (Adult) | NCT00121953 | 2004-1012 1K23HD043952-01A2 |
July 2005 | May 2008 | May 2008 | July 21, 2005 | October 17, 2012 |
|
||
139 | NCT02778919 | Recruiting | Late Phase II Clinical Study of KLH-2109 in Patients With Endometriosis |
|
|
Interventional | Phase 2 |
|
Industry |
|
Female | 20 Years and older (Adult, Senior) | NCT02778919 | KLH1204 | March 2019 | May 20, 2016 | May 23, 2016 |
|
||||||
140 | NCT02924493 | Active, not recruiting | Dietary Treatment of Endometriosis-related Irritable Bowel Syndrome |
|
|
Interventional | Not Applicable |
|
Other |
|
|
22 | Female | 18 Years to 50 Years (Adult) | NCT02924493 | Diet-in-endometriosis | July 3, 2017 | December 2017 | February 2018 | October 5, 2016 | October 27, 2017 |
|
||
141 | NCT02480647 | Completed | Clinical Trial the Use of Levonorgestrel-releasing Intrauterine System Versus Etonogestrel Implant in Endometriosis |
|
|
Interventional | Phase 4 |
|
Other |
|
|
100 | Female | 18 Years to 45 Years (Adult) | NCT02480647 | 44827415200005404 | May 2016 | August 2017 | August 2017 | June 24, 2015 | August 14, 2017 |
|
||
142 | NCT01631981 | Completed | PGL2001 Proof of Concept Study in Symptomatic Endometriosis |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
162 | Female | 18 Years to 45 Years (Adult) | NCT01631981 | PGL11-007 | AMBER | June 2012 | October 2013 | May 2014 | June 29, 2012 | June 3, 2014 |
|
|
143 | NCT00939861 | Unknown † | Laparoscopy Versus Laparotomy for Colorectal Endometriosis |
|
|
Interventional | Phase 3 |
|
Other |
|
|
52 | Female | 18 Years to 50 Years (Adult) | NCT00939861 | 13072009 | January 2006 | May 2009 | September 2009 | July 15, 2009 | July 15, 2009 |
|
||
144 | NCT01629420 | Completed | A Phase II Randomized Open Label Study of KLH-2109 in Patients With Endometriosis |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
20 | Female | 20 Years and older (Adult, Senior) | NCT01629420 | KLH1203 | June 27, 2012 | May 30, 2014 |
|
|||||
145 | NCT02350413 | Unknown † | Multicenter Italian Validation of EHP-30 |
|
|
Observational |
|
Other |
|
|
200 | Female | 18 Years to 45 Years (Adult) | NCT02350413 | ENDOCA1415 | May 2014 | September 2016 | October 2016 | January 29, 2015 | November 24, 2015 |
|
|||
146 | NCT01630252 | Completed | PGL5001 Proof of Concept Study in Inflammatory Endometriosis |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
24 | Female | 18 Years and older (Adult, Senior) | NCT01630252 | PGL11-021 | JADE | June 2012 | September 2013 | October 2013 | June 28, 2012 | June 3, 2014 |
|
|
147 | NCT01732432 | Withdrawn | Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC) |
|
Observational |
|
Other |
|
|
0 | Female | 30 Years to 85 Years (Adult, Senior) | NCT01732432 | 210/12 | EAOC | October 2012 | August 2013 | December 2013 | November 22, 2012 | April 1, 2015 | ||||
148 | NCT01697111 | Completed | Comparative Study of BAY86-5300 With an Extended Flexible Regimen for Endometriosis |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
312 | Female | 20 Years and older (Adult, Senior) | NCT01697111 | 15457 | October 2012 | March 2014 | December 2014 | October 2, 2012 | February 18, 2016 |
|
||
149 | NCT02761382 | Recruiting | Psychological Pain Treatment in Endometriosis |
|
|
Interventional | Not Applicable |
|
Other / Industry |
|
|
100 | Female | 18 Years to 47 Years (Adult) | NCT02761382 | AUENDO | March 2016 | June 2018 | June 2019 | May 4, 2016 | June 20, 2017 |
|
||
150 | NCT01533532 | Completed | A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2) |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
100 | Female | 20 Years and older (Adult, Senior) | NCT01533532 | KLH1202 | February 15, 2012 | May 30, 2014 |
|
† Study has passed its completion date and status has not been verified in more than two years.